export default function Cjc1295OverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        CJC-1295 no-DAC prompts your body to release more growth hormone by extending the natural signal from your brain to your pituitary gland. It&rsquo;s one of the most common community GH compounds, almost always stacked with Ipamorelin, and unlike synthetic GH it works with your own pulsatile release pattern rather than replacing it. The trade-off is that it genuinely alters your endocrine system &mdash; this isn&rsquo;t a gentle nudge, and your metabolic baseline matters before you start.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Average Person &mdash; Wants better recovery and body composition</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I keep hearing about this peptide stack for sleep, recovery, and looking better. Is it actually worth it or just bro-science?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>It works through your own hormones, not synthetic replacements</strong><br />Instead of injecting growth hormone directly, CJC-1295 no-DAC amplifies your brain&rsquo;s natural GH release signal. The idea is you get elevated GH without the blunter, riskier pharmacology of straight synthetic GH. For many people that feels like a more honest approach to the goal.</li>
          <li><strong>The sleep and recovery effects are reported consistently</strong><br />The most commonly reported early experience is deeper, more vivid sleep &mdash; not drowsiness, but a sense of more restorative nights. Recovery between workouts improving over weeks is the second most common report. These are the clearest near-term signals people point to.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">This is a real compound with real human endocrine data from 2006, but it shifts how your hormonal system operates, and the risks are non-trivial &mdash; glucose sensitivity, water retention, and a hard stop if you have any cancer history. It&rsquo;s almost always used alongside other compounds, training programs, and diet changes, so attributing results specifically to CJC-1295 is genuinely difficult. Body composition changes are cumulative over months, not weeks. Net: if your metabolic baseline is clean and you understand what you&rsquo;re doing, there&rsquo;s real signal here &mdash; but it&rsquo;s not a shortcut and it requires knowing which variant you have.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; Recovery-focused, body-composition conscious</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want to recover faster between hard training blocks and maybe improve my body composition. The CJC/Ipa stack is all over my training community &mdash; what should I actually know?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The CJC/Ipamorelin stack hits the GH axis from two different angles</strong><br />CJC-1295 no-DAC extends the hypothalamic GHRH signal; Ipamorelin mimics a separate ghrelin-like signal. Together they produce more GH release than either alone, while Ipamorelin is considered relatively clean with less impact on cortisol and prolactin than older GHRP compounds. Athletes value this specificity.</li>
          <li><strong>Pulsatile pattern is preserved with the no-DAC version</strong><br />The shorter half-life of the no-DAC form means you get GH pulses rather than sustained elevation &mdash; which more closely mimics natural physiology. For athletes concerned about long-term endocrine suppression, this is considered a meaningful advantage over the DAC version that blunts natural pulsatility.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The GH axis changes glucose handling &mdash; this is the most practically important concern for any athlete using this compound seriously. If your training nutrition involves high carbohydrate loading or you have any insulin sensitivity concerns, baseline glucose testing before starting is not optional. Know your version: the no-DAC and DAC variants behave so differently (hours vs. days half-life) that confusing dosing protocols is a real risk in the unregulated market. Attribution of performance improvements to CJC-1295 specifically is difficult when you&rsquo;re also training hard and eating well. Net: real tool in a sophisticated training context, requires a clean metabolic baseline and correct variant identification.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; GH axis optimization, stack design</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want to understand the CJC/Ipa stack mechanistically &mdash; specifically the pulse dynamics, the IGF-1 elevation timeline, and whether the no-DAC half-life math actually matters for the endocrine pattern.&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The GHRH + GHRP combination is mechanistically additive at different receptor levels</strong><br />CJC-1295 acts on the GHRH receptor to amplify the hypothalamic signal; Ipamorelin acts on the ghrelin receptor to trigger pituitary GH release. The combined effect exceeds either alone because they hit different parts of the same cascade. This is one of the clearest stack rationales in the community peptide world &mdash; the synergy is pharmacologically grounded.</li>
          <li><strong>IGF-1 as the downstream mediator with a measurable lag</strong><br />The body composition effects of CJC-1295 are primarily mediated by IGF-1 elevation, not GH itself. IGF-1 takes weeks of sustained GH elevation to meaningfully shift &mdash; which means anyone evaluating this compound at two or four weeks is not looking at the right timeframe for body composition. Testing IGF-1 at weeks 6&ndash;8 gives actual signal.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Long-term continuous GH-axis stimulation in healthy adults is not characterized in clinical trials. The community convention of cycling on/off periods reflects reasonable caution, not documented safety data. The cancer concern &mdash; GH and IGF-1 are mitogenic &mdash; is real and applies to any sustained GH-axis intervention. Anyone stacking multiple GH-axis compounds simultaneously (CJC + Ipa + MK-677, for instance) is adding endocrine load that has not been studied in combination. Source verification with a CoA is the minimum quality gate; the no-DAC vs DAC identity confusion in the research peptide market is a documented problem. Net: elegant stack with real mechanistic rationale, but the honest practitioner acknowledges the gaps &mdash; especially the long-term data void.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What CJC-1295 no-DAC is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Not a substitute for sleep hygiene, training consistency, or caloric discipline &mdash; it works through the same systems you build by doing those things</li>
              <li>Not a fast-acting compound &mdash; body composition effects are weeks-to-months timescale, not days</li>
              <li>Not safe to dose without knowing whether you have the DAC or no-DAC version &mdash; half-life difference of hours vs. days changes everything</li>
              <li>Not appropriate for anyone with diabetes, prediabetes, or insulin resistance without careful baseline monitoring</li>
              <li>Not safe with an active or recent cancer history &mdash; GH and IGF-1 are mitogenic signals</li>
              <li>Not equivalent to pharmaceutical-grade product &mdash; research peptide identity and purity are unregulated</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>One of few community GH compounds with published human interventional data confirming GH and IGF-1 elevation</li>
              <li>Works with your own pulsatile GH pattern rather than replacing it (especially true of the short-acting no-DAC form)</li>
              <li>The CJC/Ipamorelin stack has a mechanistically grounded rationale &mdash; two receptor systems, additive not redundant</li>
              <li>Sleep quality improvement is among the most consistently reported early experiences across communities</li>
              <li>The no-DAC vs. DAC distinction is a real pharmacological difference that separates informed users from uninformed ones</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
